• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    GigCapital 5 Inc. filed SEC Form 8-K: Other Events

    2/29/24 4:46:10 PM ET
    $GIA
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $GIA alert in real time by email
    8-K
    GigCapital5,Inc. false 0001844505 0001844505 2024-02-29 2024-02-29

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    February 29, 2024

    Date of Report (date of earliest event reported)

     

     

    GigCapital5, Inc.

    (Exact name of Registrant as specified in its charter)

     

     

     

    Delaware   001-40839   86-1728920

    (State or other jurisdiction of

    incorporation or organization)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification Number)

    1731 Embarcadero Rd., Suite 200

    Palo Alto, CA 94303

    (Address of principal executive offices)

    (650) 276-7040

    (Registrant’s telephone number, including area code)

    GigCapital5, Inc.

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☒

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbols

     

    Name of each exchange

    on which registered

    Common Stock, $0.0001 par value   QTI   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 8.01

    Other Events.

    On February 29, 2024, GigCapital5, Inc., (the “Company”) announced that its previously announced business combination with QT Imaging, Inc. will take place on March 4, 2024, and that the Company will thereafter rename itself as QT Imaging Holdings, Inc.

    A copy of the press release issued by the Company announcing the consummation of its business combination is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

    The information furnished in this Item 8.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

    Forward-Looking Statements

    This Current Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including the business combination between GigCapital5 and QT Imaging Holdings and the closing of those transactions, and statements regarding QT Imaging Holdings’s management team’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including possible business combinations, revenue growth and financial performance, product expansion and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this Current Report are based on our current expectations and beliefs made by the management of GigCapital5 and QT Imaging in light of their respective experience and their perception of historical trends, current conditions and expected future developments and their potential effects on QT Imaging and GigCapital5 as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting QT Imaging Holdings or GigCapital5 will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including regulatory approvals, the ability of the post-combination company to meet the Nasdaq listing standards, product and service acceptance, and that QT Imaging Holdings will have sufficient capital to operate as anticipated. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of GigCapital5’s filings with the SEC, and in GigCapital5’s current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this Current Report are made as of the date hereof, based on information available to GigCapital5 and QT Imaging Holdings as of the date hereof, and GigCapital5 and QT Imaging Holdings assume no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits:

     

    Exhibit    Description
    99.1    Press release, dated February 29, 2024
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated: February 29, 2024

     

    By:  

    /s/ Dr. Raluca Dinu

    Name:   Dr. Raluca Dinu
    Title:   Chief Executive Officer
    Get the next $GIA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GIA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GIA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging

      QT Imaging Holdings, Inc. Expected to Begin Trading on Nasdaq Under Ticker Symbols "QTI" on March 5, 2024 GigCapital5, Inc. (("GigCapital5", NASDAQ:GIA), a Private-to-Public Equity (PPE)™ entity also known as special purpose acquisition company ("SPAC"), today announced that the completion of their previously announced business combination (the "Business Combination") with QT Imaging, Inc. ("QT Imaging"), a technology company engaged in an innovative automated breast imaging system producing high-resolution transmission ultrasound images, will take place on March 4, 2024. The Business Combination was approved at an Annual Meeting of GigCapital5's stockholders on February 20, 2024. Upon co

      2/29/24 4:45:00 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Shareholder Approval of Business Combination

      GigCapital5, Inc. ("GigCapital5") (NASDAQ:GIA) today announced that at the Annual Meeting of GigCapital5's stockholders (the "Annual Meeting") held on February 20, 2024, GigCapital5's stockholders voted to approve the previously announced proposed business combination between GigCapital5, QT Imaging, Inc. ("QT Imaging") and QTI Merger Sub, Inc. ("Merger Sub"), as well as all other proposals related to the Business Combination. GigCapital5 plans to file the results of the Annual Meeting, as tabulated by an independent inspector of elections, on Form 8-K with the Securities and Exchange Commission today. About GigCapital5 On December 8, 2022, GigCapital5 entered into a Business Combinat

      2/22/24 9:00:00 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    SEC Filings

    See more
    • SEC Form 8-K filed by GigCapital 5 Inc.

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/18/24 5:00:32 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Other Events

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/15/24 9:01:02 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/8/24 5:04:04 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:33:56 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:30:25 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by GigCapital 5 Inc. (Amendment)

      SC 13G/A - GigCapital5, Inc. (0001844505) (Subject)

      2/22/24 8:39:14 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Budagov Stas

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:36:16 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Weiner Zeev

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:18:19 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Dickson Daniel

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:17:06 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Leadership Updates

    Live Leadership Updates

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care